Claritas Pharmaceuticals, Inc.
CLAZFOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$3659
P/E Ratio—
52W High$0.0001
52W Low$0.0001
Claritas Pharmaceuticals, Inc. (CLAZF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CLAZF · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2020-12 | 2019-12 | 2018-12 | 2017-12 | 2016-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | $0.00B | $0.00B | $0.00B | $0.00B | ($0.00B) |
| Gross Margin %(computed) | — | — | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | ($0.00B) | $0.01B | $0.01B | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | ($0.00B) | $0.01B | $0.01B | $0.01B | $0.01B |
| Operating Income | ($0.00B) | ($0.01B) | ($0.01B) | ($0.01B) | ($0.01B) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.02B | $0.00B |
| Income Before Tax | ($0.00B) | ($0.03B) | $0.01B | ($0.03B) | ($0.01B) |
| Income Tax Expense | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) | $0.00B |
| Net Income | $0.00B | ($0.02B) | $0.01B | ($0.03B) | ($0.01B) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.16 | $-0.95 | $0.55 | $-5.20 | $-7.86 |
| Wtd Avg Shares | 0.03B | 0.02B | 0.01B | 0.01B | 0.00B |
| EBITDA | ($0.00B) | ($0.02B) | $0.02B | ($0.02B) | ($0.01B) |
| EBITDA Margin %(computed) | — | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Claritas Pharmaceuticals, Inc. data
About Claritas Pharmaceuticals, Inc. (CLAZF) Income Statement
Claritas Pharmaceuticals, Inc. (CLAZF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2020, CLAZF reported revenue of $0.00B, gross profit of $0.00B (gross margin —), and net income of $0.00B — a net profit margin of —.
Frequently asked questions
CLAZF · 4 questionsClaritas Pharmaceuticals, Inc. (CLAZF) reported revenue of $0.00B for 2020, down —% year-over-year.
CLAZF revenueCLAZF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08